Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pria Diagnostics was a medical technology company that specialized in miniaturized advanced diagnostics using microelectromechanical systems (MEMS) and microfluidics. Based in Menlo Park, California, the company developed the Element home fertility-testing device, which provided a rapid and private method for men to assess sperm motility and concentration. The company's core technology platform, NanoFL, utilized high-sensitivity fluorescence detection for a variety of diagnostic applications, including infectious diseases and autoimmune disorders. Pria Diagnostics aimed to transition complex laboratory tests into portable, point-of-care formats for consumer and clinical use. In August 2009, the company's intellectual property and assets were acquired by QuantRx Biomedical for approximately $725,000.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pria Diagnostics.